AstraZeneca, CRISPR tools supplier Synthego ink gene editing enzyme licensing deal

Genome engineering business Synthego will have access to AstraZeneca’s CRISPR gene editing enzyme in its second licensing agreement in the past year. Synthego plans on combining the enzyme, branded as eSpOT-ON, with its RNA guides ...